Chamberlain, Chester E. et al
"A Patient-derived Xenograft Model of Pancreatic Neuroendocrine Tumors Identifies Sapanisertib as a Possible New Treatment for Everolimus-resistant Tumors." Molecular Cancer Therapeutics
17.12
(2018):
2702-2709.
Web. 28 Jan. 2020.
